Correlation Between Nkarta and Kronos Bio
Can any of the company-specific risk be diversified away by investing in both Nkarta and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Kronos Bio, you can compare the effects of market volatilities on Nkarta and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Kronos Bio.
Diversification Opportunities for Nkarta and Kronos Bio
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Nkarta and Kronos is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of Nkarta i.e., Nkarta and Kronos Bio go up and down completely randomly.
Pair Corralation between Nkarta and Kronos Bio
Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the Kronos Bio. In addition to that, Nkarta is 1.2 times more volatile than Kronos Bio. It trades about -0.24 of its total potential returns per unit of risk. Kronos Bio is currently generating about 0.05 per unit of volatility. If you would invest 94.00 in Kronos Bio on September 12, 2024 and sell it today you would earn a total of 8.00 from holding Kronos Bio or generate 8.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Nkarta Inc vs. Kronos Bio
Performance |
Timeline |
Nkarta Inc |
Kronos Bio |
Nkarta and Kronos Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nkarta and Kronos Bio
The main advantage of trading using opposite Nkarta and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.Nkarta vs. Monte Rosa Therapeutics | Nkarta vs. Lyell Immunopharma | Nkarta vs. Generation Bio Co | Nkarta vs. Sana Biotechnology |
Kronos Bio vs. Cyclerion Therapeutics | Kronos Bio vs. Larimar Therapeutics | Kronos Bio vs. Addex Therapeutics | Kronos Bio vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |